Request Sample Inquiry
Digital Therapeutics Market

Digital Therapeutics Market

Digital Therapeutics Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

156

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1327

Segments Covered
  • By Application By Application Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others
  • By End-Use By End-Use Patients, Providers, Payers, Employers, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 4.8 Billion
Revenue 2030Revenue 2030: USD 18.72 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 30.08%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. Global Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. Global Digital Therapeutics Market - by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. Global Digital Therapeutics Market - by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. Global Digital Therapeutics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. North America Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. North America Digital Therapeutics Market, by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. North America Digital Therapeutics Market, by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. North America Digital Therapeutics Market, by Country
      1. U.S.
        1. U.S. Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. U.S. Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      2. Canada
        1. Canada Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Canada Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      3. Mexico
        1. Mexico Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Mexico Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
  5. Europe Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. Europe Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. Europe Digital Therapeutics Market, by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. Europe Digital Therapeutics Market, by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. Europe Digital Therapeutics Market, by Country
      1. Germany
        1. Germany Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Germany Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      2. UK
        1. UK Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. UK Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      3. France
        1. France Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. France Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      4. Spain
        1. Spain Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Spain Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      5. Italy
        1. Italy Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Italy Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      6. BENELUX
        1. BENELUX Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. BENELUX Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      7. Rest of Europe
        1. Rest Of Europe Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Rest Of Europe Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
  6. Asia Pacific Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Digital Therapeutics Market, by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. Asia Pacific Digital Therapeutics Market, by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. Asia Pacific Digital Therapeutics Market, by Country
      1. China
        1. China Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. China Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      2. Japan
        1. Japan Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Japan Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      3. India
        1. India Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. India Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      4. South Korea
        1. South Korea Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. South Korea Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      5. South East Asia
        1. South East Asia Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. South East Asia Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Rest of Asia Pacific Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
  7. Latin America Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. Latin America Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. Latin America Digital Therapeutics Market, by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. Latin America Digital Therapeutics Market, by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. Latin America Digital Therapeutics Market, by Country
      1. Brazil
        1. Brazil Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Brazil Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      2. Argentina
        1. Argentina Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Argentina Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      3. Rest of Latin America
        1. Rest of Latin America Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Rest of Latin America Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
  8. Middle East & Africa Digital Therapeutics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Digital Therapeutics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Digital Therapeutics Market, by Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    4. Middle East & Africa Digital Therapeutics Market, by End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
    5. Middle East & Africa Digital Therapeutics Market, by Country
      1. GCC Countries
        1. GCC Countries Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. GCC Countries Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      2. South Africa
        1. South Africa Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. South Africa Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Digital Therapeutics Market, By Application
          1. By Diabetes
          2. By Obesity
          3. By CVD
          4. By CNS Disease
          5. By Respiratory Diseases
          6. By Smoking Cessation
          7. By Others
        2. Rest of Middle East & Africa Digital Therapeutics Market, By End-Use
          1. By Patients
          2. By Providers
          3. By Payers
          4. By Employers
          5. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Omada Health Inc. (US)
    2. WellDoc Inc. (US)
    3. 2Morrow Inc (US).
    4. Livongo Health (US)
    5. Propeller Health (US)
    6. Pear Therapeutics (US)
    7. Canary Health Inc. (US)
    8. Noom Health Inc. (US)
    9. Mango Health Inc. (US)
    10. Akili Interactive Labs (South Africa)
    11. Better Therapeutics (US)
    12. Happify Health (US)
    13. Kaia Health (US)
    14. Medtronic Plc. (Ireland)
    15. Teladoc Health Inc (US)
    16. and Fitbit Health Solutions (US).
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 24-Feb-2022
Digital Therapeutics Market Anticipated to Reach USD 14.52 Billion by 2028
FAQ
Frequently Asked Question

  • The global Digital Therapeutics valued at USD 4.8 Billion in 2022 and is expected to reach USD 18.72 Billion in 2030 growing at a CAGR of 30.08%.

  • The prominent players in the market are Omada Health Inc. (US), WellDoc Inc. (US), 2Morrow Inc (US)., Livongo Health (US), Propeller Health (US), Pear Therapeutics (US), Canary Health Inc. (US), Noom Health Inc. (US), Mango Health Inc. (US), Akili Interactive Labs (South Africa), Better Therapeutics (US), Happify Health (US), Kaia Health (US), Medtronic Plc. (Ireland), Teladoc Health Inc (US), and Fitbit Health Solutions (US)..

  • The market is project to grow at a CAGR of 30.08% between 2023 and 2030.

  • The driving factors of the Digital Therapeutics include

    • Increased Adoption of EHR Solutions

  • North America was the leading regional segment of the Digital Therapeutics in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy